Increase in the prevalence of anxiety disorders and depression is bolstering the Global Anxiety Disorders and Depression Treatment Market
Glance our 200 slides market research and competitive intelligence research report, 25 Tables and 65 Figures and other qualitative sections with an in-depth TOC on "Global Anxiety Disorders and Depression Treatment Market: By Product Type (MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics, Benzodiazepines, Anticonvulsants, Beta-Blockers, SRIs (Selective Serotonin Reuptake Inhibitors), SNRIs (Serotonin-Norepinephrine Reuptake Inhibitors), TeCAs (Tetracyclic Antidepressants), TCAs (Tricyclic Antidepressants), Others), By Distribution Channel (Hospital Pharmacies, Online Pharmacies, Others), and Geography- Global/Region/Country Forecast to 2028."
View Detailed Report Description: https://precisionbusinessinsights.com/market-reports/anxiety-disorders-and-depression-treatment-market/
The growing geriatric population along with mental disorders is fuelling the Anxiety Disorders and Depression Treatment Market:
Anxiety varies from the feeling of nervousness. It is a disorder involves extreme anxiety. It is a normal reaction to stress. Anxiety disorders are one of the most common mental disorders affect almost 30% of adults at some point in their lives according to the American Psychiatric Association. Anxiety disorder cannot lessen however can get worse over a period of time. Feelings can interfere with everyday activities. Different types of anxiety disorders are there including panic disorder and social anxiety disorder.
One of the major factors fuelling the anxiety disorders and depression treatment market is the increasing prevalence of anxiety disorder and depression. Over 300 million people of all ages are suffering from depression problem worldwide in which 800,000 people die because of the suicide of which depression and anxiety disorders are a major cause according to the World Health Organization (WHO). Growing demand for the antidepressants may be attributed to the market growth. Growing ageing population along with mental disorders is boosting the anxiety disorders and depression treatment market growth. On the other hand, factors including growing adoption of the other treatment options like herbal treatment and patent expiry of the drugs are anticipated to hamper the market growth. Growing generic drugs are likely to hamper the anxiety disorders and depression treatment market growth.
North America accounted for major share in the Anxiety Disorders and Depression Treatment Market:
The global anxiety disorders and depression treatment market is categorized into key regions such as Asia Pacific, North America, Latin America, Middle East, Africa and Europe. North America market is the leading market as compared to other geographical markets. Anxiety disorders are the most common mental health issue in the U.S according to the National Alliance on Mental Illness. In 2014, one in every five adults is suffering from mental health problem according to the Mental Health America. This condition is examined to be worsening rapidly in youth. The Asia Pacific anxiety disorders and depression treatment market is anticipated to reveal a luxurious growth over the evaluation time span.
Request sample report at https://precisionbusinessinsights.com/request-sample?product_id=23200
Competitive Analysis - Global Anxiety Disorders and Depression Treatment Market:
Major players operating in the global anxiety disorders and depression treatment market are MAOIs (Monoamine Oxidase inhibitors), Atypical Antipsychotics,, Benzodiazepines, Anticonvulsants, Beta-Blockers and SRIs (Selective Serotonin Reuptake Inhibitors). Key players in the market aim at following strategies such as major collaborations and acquisitions.
Precision Business InsightsTM | Toll Free: +1 866 598 1553
Kemp House, 152 - 160 City Road, London EC1V 2NX
Web: https://precisionbusinessinsights.com/ | D U N S® Number: 852781747
About Precision Business Insights:
We are a market research company that strives to provide the highest quality market research insights. Our diverse market research experts are enthusiastic about market research and therefore produce high-quality research reports. We have over 500 clients with whom we have a good business partnership and capacity to provide in-depth research analysis for more than 30 countries. In addition to deliver more than 150 custom solutions, we already have accounts with the top five medical device manufacturers.
Precision Business Insights offers a variety of cost-effective and customized research services to meet research requirements. We are a leading research service provider because of our extensive database built by our experts and the services we provide.
This release was published on openPR.
Permanent link to this press release:
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Increase in the prevalence of anxiety disorders and depression is bolstering the Global Anxiety Disorders and Depression Treatment Market here
News-ID: 2645429 • Views: 346
More Releases from Precision Business Insights
Interventional Oncology Market Size, Growth Drivers 2022-28
The global interventional oncology market size was valued at USD 2.1 billion in 2021 and is poised to grow at a significant CAGR of 6.8% during the forecast period 2022-28. A branch of interventional radiology called interventional oncology (IO) deals with employing imaging-guided minimally invasive treatments to diagnose and treat cancer and disorders connected to it. Interventional oncologists with this specialty actively work on the diagnosis and management of
Cancer Vaccines Market Size, Trends, Share, Report 2022-28
The global cancer vaccines market size was valued at USD 4.5 billion in 2021 and is poised to grow at a significant CAGR of 14.1% during the forecast period 2022-28. Cancer is a malignant tumor brought on by the body's unchecked expansion of aberrant cells. It can be treated by using a variety of drugs and vaccinations. Vaccines fall largely into the categories of preventative and therapeutic among these.
PU Elastomers Market Leading Player 2022-28
The global pu elastomers market size was valued at USD 15.4 billion in 2021 and is poised to grow at a significant CAGR of 5.1% during the forecast period 2022-28. Given their flexibility, toughness, load strength, abrasion resistance, and chemical resistance, polyurethane elastomers are well known for their employment in a variety of industries. The rise of the global population is one of the key factors predicted to propel the
Vaccine Vials Market Size | Share | Industry Analysis 2022-2028
The global vaccine vials market size was valued at USD 520.2 billion in 2021 and is poised to grow at a significant CAGR of 10.6% during the forecast period 2022-28. Vials used to store liquid medications are small, cylindrical containers made of glass called vaccine vials. They have a strong enzyme resistance and a mediocre resistance to temperature changes. They do not interact with the substance housed within because they
More Releases for Anxiety
How to reduce anxiety in 2022
London, England – knus is excited to announce the launch of the 30-day anxiety plan, a free online mental health course that helps reduce anxiety. The official launch date for the 30-day anxiety plan is 1st January 2022. The 30-day anxiety plan by knus has been designed by those with a lived experience of mental health and has shown to reduce anxiety symptoms in those that complete the plan. The
Free Hypnosis Download for Coronavirus Anxiety
Eli Bliliuos, founder and President, of NYC Hypnosis Center has just released a free hypnosis download to help anyone who is suffering from anxiety and stress due to the Coronavirus pandemic. The free Hypnosis MP3 for Coronavirus Anxiety (24 hours only), called "Clear Your Mind", can provide a break from the repetitive thoughts related to the outbreak. It can help program the mind to recognize that this Coronavirus pandemic will
No fear! Neuropeptide may aid targeted anxiety therapy
The targeted control of biochemical processes and neuronal signalling pathways using the messenger substance neuropeptide Y could help in the future treatment of anxiety disorders. This is demonstrated in research findings by the Austrian Science Fund FWF, which were recently published in the scientific journal "Neuropsychopharmacology". Palpitations, sweating and sleep problems – most people have already experienced symptoms of anxiety. As a response to danger, fear is vital for our survival.
No Pain, No Anxiety, Exceptional Care
NYC Smile Design finds the perfect balance to patient care, by using the latest advances in dental technology to treat pain and anxiety, and extending its extraordinary cosmetic and technical skills to treating the whole patient. Hailed by Newsweek as “two of Manhattan's most respected and accomplished cosmetic dentists,” Drs. Ramin Tabib and Elisa Mello have perfected a new treatment strategy that guarantees their patients pain-free and relaxed visits to the
AboutKidsHealth advises on phobias and anxiety in children
AboutKidsHealth, leading online Canadian source for children’s health information, looks into what steps parents of children with phobias can take to help. As a child, John Greene looked forward to the day when the end-of-summer carnival rolled into his hometown. For months leading up to the highly anticipated event, he would set aside a portion of his total allowance – a mere 75 cents, he recalls – to spend on sticks
Get Anxiety Relief without Medication
A lot of people look for anti-depressants for anxiety relief but these anti-depressants are often a cause of the manic symptoms, which is a result of overproduction of neurotransmitters. Panic attacks can happen to anybody during any phase of time and often it comes crashing against your body and mind. The syndrome has a number of symptoms like fast and hard heart beating, a sense of losing control, shortness of